Level 2 Β· Exploration
AI Watching the Literature
How do you build an AI-assisted evidence surveillance system that keeps a WHO India brief current β without running a full review every time something changes?
A well-conducted literature review has a shelf life. For health financing and UHC topics in India, that shelf life is often shorter than the policy cycle it is meant to inform. PM-JAY implementation data accumulates quarterly. NHA accounts are released annually. HTAIn publishes new assessments on a rolling basis. Budget Union statements shift the fiscal landscape. A brief produced in January may be materially outdated by the time it reaches a decision-maker in August.
The conventional response β running a new full systematic review whenever the evidence base shifts β is not realistic at WHO India's operating tempo. Evidence surveillance is the alternative: a structured, lightweight monitoring system that detects when new evidence is significant enough to update a brief, without requiring a full review to find out.
AI tools are well-suited to surveillance. They can monitor keyword combinations, flag new publications, screen abstracts against your inclusion criteria, and summarise what has changed. The challenge is not the technology β it is designing the surveillance protocol so that the signal-to-noise ratio stays high enough to be actionable rather than overwhelming.
Not every topic warrants the same surveillance investment. Calibrate by how fast the evidence base moves and how consequential a missed update would be:
Generic keyword alerts produce noise. For WHO India health financing work, the high-value signals are specific. Monitor these sources and triggers with the highest priority:
| Source | What to watch for | Priority | Update trigger |
|---|---|---|---|
| HTAIn (htain.mohfw.gov.in) | New assessments on any intervention in your brief's topic area | High | Any new HTAIn report overrides LMIC-extrapolated cost-effectiveness evidence |
| National Health Accounts India | Annual NHA release β OOP expenditure share, state-level financing data | High | Updated OOP figures may change the baseline financial risk picture materially |
| PM-JAY / NHA (National Health Authority) | Quarterly claims data, state empanelment reports, beneficiary utilisation | High | Claims settlement rates below 60% in a key state change the implementation feasibility evidence |
| PubMed β India health financing | New economic evaluations, PM-JAY impact studies, state insurance evaluations | Medium | New RCT or well-designed DiD study with India-specific financial protection outcomes |
| Union Budget / State Budgets | Health allocation changes, NHM funding, PM-JAY budget revision | High | Material change in fiscal space for the intervention under review |
| WHO IRIS / World Bank OKR | New LMIC systematic reviews on health financing, UHC progress reports | Medium | New systematic review that includes India or South Asia with disaggregated results |
| NITI Aayog / MoHFW reports | State health index, NHP progress reports, disease burden updates | Routine | New data that changes the population-level burden estimate underlying the brief's framing |
Surveillance is only useful if it generates a clear decision: does this new finding change the brief, and if so, how? Here is how to process a new signal:
Describe a live WHO India topic you are monitoring or a brief you have recently produced. The tool will generate a structured surveillance protocol β sources, cadence, screening prompts, and update triggers β calibrated to your specific topic.
Evidence surveillance is the system that prevents a well-built brief from becoming a liability when the evidence base moves. The three tiers match surveillance intensity to topic velocity. The India-specific signal list prioritises HTAIn, NHA, and PM-JAY operational data above generic PubMed alerts β because those sources move faster and matter more for WHO India policy than any journal publication. Build the surveillance plan before you circulate the brief. The moment a brief reaches a decision-maker is the moment it starts ageing.